Skip to main content
Clinical Trials/EUCTR2009-010804-27-IT
EUCTR2009-010804-27-IT
Active, not recruiting
Not Applicable

ROLE OF NITRIC OXIDE IN LUNG INFLAMMATION OF COPD PATIENTS - ND

AZIENDA OSPEDALIERA POLICLINICO DI MODENA0 sitesStarted: July 30, 2009Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
AZIENDA OSPEDALIERA POLICLINICO DI MODENA

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • COPD outpatients in stage II and III of GOLD classification. Patients will be smokers or ex\-smokers since at least 6\-months, with a similar degree of severity, while on their usual drug therapy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • No actual use of steroids or antioxidants (i.e. N\-acetilcysteine), no evidence of exacerbation in the preceeding 4 weeks.

Investigators

Sponsor
AZIENDA OSPEDALIERA POLICLINICO DI MODENA

Similar Trials